These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 15450367)
1. Age-related changes in nigrostriatal dopaminergic function are accentuated in +/- brain-derived neurotrophic factor mice. Dluzen DE; McDermott JL; Anderson LI; Kucera J; Joyce JN; Osredkar T; Walro JM Neuroscience; 2004; 128(1):201-8. PubMed ID: 15450367 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Dluzen DE; Gao X; Story GM; Anderson LI; Kucera J; Walro JM Exp Neurol; 2001 Jul; 170(1):121-8. PubMed ID: 11421589 [TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine output is compromised within +/- BDNF mice. Dluzen DE; Anderson LI; McDermott JL; Kucera J; Walro JM Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489 [TBL] [Abstract][Full Text] [Related]
4. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice. Dluzen DE Neurosci Lett; 2004 Apr; 359(3):135-8. PubMed ID: 15050682 [TBL] [Abstract][Full Text] [Related]
5. Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity. Dluzen DE; McDermott JL Ann N Y Acad Sci; 2004 Oct; 1025():205-20. PubMed ID: 15542719 [TBL] [Abstract][Full Text] [Related]
6. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Dluzen DE; Story GM; Xu K; Kucera J; Walro JM Exp Neurol; 1999 Dec; 160(2):500-7. PubMed ID: 10619567 [TBL] [Abstract][Full Text] [Related]
7. Age-related changes in nigrostriatal dopaminergic function in heterozygous mutant dopamine transporter knock-out mice. Dluzen DE; Ji J; McDermott JL Neurosci Lett; 2010 May; 476(2):66-9. PubMed ID: 20382201 [TBL] [Abstract][Full Text] [Related]
8. Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice. Baker SA; Stanford LE; Brown RE; Hagg T Brain Res; 2005 Mar; 1039(1-2):177-88. PubMed ID: 15781060 [TBL] [Abstract][Full Text] [Related]
9. Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system. Dluzen DE; Mickley KR Pharmacol Biochem Behav; 2005 Jan; 80(1):27-33. PubMed ID: 15652377 [TBL] [Abstract][Full Text] [Related]
11. Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain. Yurek DM; Fletcher-Turner A Exp Neurol; 2000 Jan; 161(1):392-6. PubMed ID: 10683304 [TBL] [Abstract][Full Text] [Related]
12. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice. Zaman V; Nelson ME; Gerhardt GA; Rohrer B Exp Neurol; 2004 Dec; 190(2):337-46. PubMed ID: 15530873 [TBL] [Abstract][Full Text] [Related]
13. Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. Luellen BA; Bianco LE; Schneider LM; Andrews AM Genes Brain Behav; 2007 Jul; 6(5):482-90. PubMed ID: 17156118 [TBL] [Abstract][Full Text] [Related]
14. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway. Enna SJ; Reisman SA; Stanford JA Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350 [TBL] [Abstract][Full Text] [Related]
15. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504 [TBL] [Abstract][Full Text] [Related]
17. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease. Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433 [TBL] [Abstract][Full Text] [Related]
18. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice. Küppers E; Krust A; Chambon P; Beyer C Psychoneuroendocrinology; 2008 Jul; 33(6):832-8. PubMed ID: 18472350 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of brain-derived neurotrophic factor in BDNF(+/-) mice is associated with enhanced recovery of motor performance and increased neuroblast number following experimental stroke. Nygren J; Kokaia M; Wieloch T J Neurosci Res; 2006 Aug; 84(3):626-31. PubMed ID: 16770774 [TBL] [Abstract][Full Text] [Related]
20. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]